Halo Neuroscience

Halo Neuroscience developed the Halo Sport neurostimulation headset, which uses transcranial direct current stimulation (tDCS) to enhance athletic performance by accelerating muscle memory and motor learning. Originally targeted at elite athletes and military users, the technology applies gentle electrical current to the motor cortex during training to boost neuroplasticity. The company subsequently pivoted toward consumer wellness, repositioning the device to support mood, sleep, and focus in healthy adults. Halo was later acquired by Flow Neuroscience, a Swedish med-tech company that developed Europe's first medically certified at-home tDCS device for depression treatment. The combined platform now serves both performance and clinical wellness markets.